Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Time-to-event analyses for long-term treatments--the APPROVe trial.

× No keyword cloud information.

9 in total

1. The prevention and treatment of missing data in clinical trials.

Authors: Roderick J Little; Ralph D'Agostino; Michael L Cohen; Kay Dickersin; Scott S Emerson; John T Farrar; Constantine Frangakis; Joseph W Hogan; Geert Molenberghs; Susan A Murphy; James D Neaton; Andrea Rotnitzky; Daniel Scharfstein; Weichung J Shih; Jay P Siegel; Hal Stern
Journal: N Engl J Med Date: 2012-10-04 Impact factor: 91.245

2. Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control study.

Authors: Deirdre P Cronin-Fenton; Lars Pedersen; Timothy L Lash; Søren Friis; John A Baron; Henrik T Sørensen
Journal: Breast Cancer Res Date: 2010-03-01 Impact factor: 6.466

3. Neoplasms escape selective COX-2 inhibition in an animal model of breast cancer.

Authors: M Barry; R A Cahill; G Roche-Nagle; T G Neilan; A Treumann; J H Harmey; D J Bouchier-Hayes
Journal: Ir J Med Sci Date: 2009-04-02 Impact factor: 1.568

4. Non-Esterified Fatty Acids and Risks of Frailty, Disability, and Mobility Limitation in Older Adults: The Cardiovascular Health Study.

Authors: Peter Ahiawodzi; Luc Djousse; Joachim H Ix; Jorge R Kizer; Russell P Tracy; Alice Arnold; Anne Newman; Kenneth J Mukamal
Journal: J Am Geriatr Soc Date: 2020-09-22 Impact factor: 5.562

5. A randomized trial of the peri-operative use of COX-2 inhibitors in Lichtenstein herniorrhaphy.

Authors: K Turaga; A Wright; R Lee; W P C Dias; C Destache; R Christian; R J Fitzgibbons
Journal: Hernia Date: 2008-06-14 Impact factor: 4.739

6. Initially fewer bloodstream infections for allogeneic vs. autologous stem-cell transplants in neutropenic patients.

Authors: S Hieke; H Bertz; M Dettenkofer; M Schumacher; J Beyersmann
Journal: Epidemiol Infect Date: 2012-03-07 Impact factor: 4.434

7. Response to commentary by Dixon and Silman on the systematic review and meta-analysis by Bongartz et al.

Authors: Eric L Matteson; Tim Bongartz; Alex J Sutton; Iain Buchan
Journal: Arthritis Res Ther Date: 2006 Impact factor: 5.156

8. Impact of the World Health Organization Pain Treatment Guidelines and the European Medicines Agency Safety Recommendations on Nonsteroidal Anti-Inflammatory Drug Use in Lithuania: An Observational Study.

Authors: Skaistė Kasciuškevičiūtė; Gintautas Gumbrevičius; Aušra Vendzelytė; Arūnas Ščiupokas; Kęstutis Petrikonis; Edmundas Kaduševičius
Journal: Medicina (Kaunas) Date: 2018-05-11 Impact factor: 2.430

Review 9. Missing data in randomised controlled trials of rheumatoid arthritis drug therapy are substantial and handled inappropriately.

Authors: Nasim A Khan; Karina D Torralba; Fawad Aslam
Journal: RMD Open Date: 2021-07

9 in total